Indivior Pharmaceuticals, Inc. Share Price
Stocks
INDV
US45579U1097
Pharmaceuticals
OTC Markets Traded|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 39.84 USD | +3.98% |
|
+4.45% | +10.65% |
| 06-18 | Barclays Initiates Indivior at Overweight With $46 Price Target | MT |
| 06-10 | Indivior Pharmaceuticals Insider Sold Shares Worth $1,357,200, According to a Recent SEC Filing | MT |
| Market Cap | 4.67B 4.1B 3.78B 3.54B 6.63B 443B 6.75B 45.41B 17.58B 217B 17.54B 17.16B 755B | P/E 2026 * |
12.1x | P/E 2027 * | 11.1x |
|---|---|---|---|---|---|
| Enterprise Value | 4.73B 4.15B 3.83B 3.58B 6.71B 448B 6.82B 45.94B 17.78B 220B 17.74B 17.36B 764B | EV / Sales 2026 * |
3.76x | EV / Sales 2027 * | 3.32x |
| Free-Float |
94.92% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Indivior Pharmaceuticals, Inc.
| 1 day | +3.25% | ||
| 1 week | +4.53% | ||
| Current month | +10.30% | ||
| 1 month | +5.08% | ||
| 3 months | +35.18% | ||
| 6 months | +9.30% | ||
| Current year | +10.73% |
| 1 week | 37.64 |  | 39.81 |
| 1 month | 32.41 | | 39.81 |
| Current year | 27.68 | | 41 |
| 1 year | 13.47 | | 41 |
| 3 years | 7.33 | | 41 |
| 5 years | 7.33 | | 41 |
| 10 years | 1.75 | | 41 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-10 | Sell | Chief Scientific Officer | -18,586 | 0.0152% | ||
| 06-07 | Sell | Chief Financial Officer | -36,000 | 0.0295% | ||
| 05-12 | Free | Director | 6,518 | 0.0053% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.25% | +4.53% | +184.80% | +74.25% | 4.67B | |
| +0.17% | -1.63% | +43.28% | +140.64% | 983B | |
| +2.37% | +0.70% | +56.50% | +43.11% | 557B | |
| +2.06% | +5.55% | +27.78% | +72.76% | 406B | |
| +1.53% | -1.93% | +23.33% | +16.35% | 314B | |
| +2.26% | +2.30% | +30.42% | +18.98% | 273B | |
| +2.61% | +3.11% | +29.81% | +36.09% | 272B | |
| +2.60% | +9.79% | -31.71% | -43.45% | 203B | |
| +0.92% | +0.03% | +27.71% | +53.20% | 186B | |
| +0.81% | -1.18% | +18.40% | +62.30% | 155B | |
| Average | +1.95% | -0.85% | +41.03% | +47.42% | 335.5B | |
| Weighted average by Cap. | +1.57% | -2.21% | +33.22% | +66.47% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.26B 1.11B 1.02B 953M 1.79B 119B 1.82B 12.23B 4.73B 58.47B 4.72B 4.62B 203B | 1.29B 1.13B 1.04B 976M 1.83B 122B 1.86B 12.51B 4.84B 59.84B 4.83B 4.73B 208B |
| Net income | 414M 364M 336M 314M 588M 39.26B 598M 4.03B 1.56B 19.26B 1.56B 1.52B 66.95B | 455M 400M 368M 345M 646M 43.09B 657M 4.42B 1.71B 21.14B 1.71B 1.67B 73.49B |
| Net Debt | 54.5M 47.88M 44.12M 41.3M 77.38M 5.16B 78.68M 530M 205M 2.53B 205M 200M 8.8B | -403M -354M -327M -306M -573M -38.21B -582M -3.92B -1.52B -18.75B -1.51B -1.48B -65.17B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 23/06/26 | US$39.71 | +3.63% | 778,690 |
| 22/06/26 | US$38.32 | +0.05% | 1,234,669 |
| 18/06/26 | US$38.30 | +0.98% | 4,276,876 |
| 17/06/26 | US$37.93 | -0.21% | 1,485,122 |
| 16/06/26 | US$38.01 | -1.02% | 1,256,102 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- INDV Stock
Select your edition
All financial news and data tailored to specific country editions
